INSIGHTS ON CLINICAL TRIAL DESIGN
-
Inspection Facilitation Without Local MAH Presence
Local expertise and centralized oversight ensured compliant, well‑coordinated inspections across countries, reducing operational risk and client burden while maintaining consistent authority engagement.
-
Guiding GLP-1 Participants Through The Challenge Of Retention
Learn how remote lifestyle coaching can combat high dropout rates in metabolic research by offering the support participants need to maintain adherence and ensure data integrity.
-
The Story Behind MIDBA: An Exclusive Interview
A new regulatory framework reduces PK bridging study needs, helping sponsors streamline device transitions, lower costs, speed up timelines, and boost regulatory predictability for combination products.
-
5 RWE Approaches That Strengthen Precision Oncology
Real-world evidence is becoming vital in precision oncology. Discover five creative, practical ways sponsors can use RWE to fuel development, sharpen regulatory strategy, and strengthen market access.
-
Accelerating Enrollment And Upholding Quality In Complex Oncology Trials5/5/2026
Real-world oncology trials reveal how fast physician engagement, hands-on biomarker management, and adaptive enrollment shorten timelines, reach first-patient milestones, and preserve data quality.
-
"We'll Figure It Out Later" Is Where Trial Friction Begins6/19/2026
Delayed operational decisions around travel, payments, site workflows, meetings, and compliance can create avoidable friction for sites, participants, sponsors, and CROs once a study is underway.
-
4 Proven Strategies To Optimize Patient Enrollment, Avoid Rescue Trials5/9/2025
Though rescue studies are common, there are ample tactics to avoid these situations altogether, including robust planning, data analysis, and prioritization of patient recruitment and retention.
-
How RWD Reshapes Patient Recruitment Strategies8/13/2025
Discover how real-world data (RWD) is transforming patient recruitment by shifting from traditional site-centered methods to a patient-first approach.
-
Scaling Outsourced Clinical Trial Services6/16/2026
Scaling outsourced clinical services increases operational pressure. Here’s where strain appears, how structure absorbs volume, and what sponsors should evaluate as programs expand.
CLINICAL TRIAL DESIGN SOLUTIONS
-
Enable consistent protocol execution with standardized workflows for training, monitoring, documentation, inventory, and drug accountability.
-
Veristat harnesses knowledge, expertise, and scale to provide superior solutions and progressive approaches to mitigate risks and achieve meaningful outcomes for biopharmaceutical and medical technology companies, and their patients.
-
Block Clinical provides a single point of contact for Patients and Sites who support them throughout their journey, from start to finish.
-
Direct-to-patient shipments are reshaping decentralized trials by placing patient convenience at the center of study design.
-
Strengthen trial compliance and data integrity by mastering GCP through practical, real-world scenarios designed to prevent costly errors and ensure audit readiness across your research team.